University of Wisconsin-Madison School of Medicine and Public Health, Department of Ophthalmology and Visual Sciences, 53726, USA.
Am J Ophthalmol. 2010 Jul;150(1):55-62.e2. doi: 10.1016/j.ajo.2010.02.013.
To examine the prevalence of macular telangiectasia type 2 and lesions characterizing it.
Population-based cohort study.
setting: City and township of Beaver Dam, 1988-1990. study population: A total of 4790 people 43-86 years of age. observation procedure(s): Grading from stereoscopic fundus photographs to measure macular telangiectasia type 2. main outcome measure: Prevalent macular telangiectasia type 2.
Macular telangiectasia type 2 was present at baseline in 0.1% of the population (95% confidence interval [CI] 0.09, 0.1). The frequencies of loss of retinal transparency, crystals in the inner retinal layers, blunted retinal vessels, localized intraretinal pigment migration in the juxtafoveolar region, and presence of yellow deposits and lamellar holes in the foveal area in those without macular telangiectasia type 2 varied from 0.06% for retinal telangiectatic vessels to 1.2% for lamellar holes. Smoking was associated with pigment clumping (odds ratio [OR] per pack year 1.02; 95% CI 1.00, 1.03; P = .02), retinal pigment epithelial (RPE) depigmentation (OR 1.02 per pack year; 95%CI 1.00, 1.04; P = .02), loss of transparency (OR 1.02 per pack year; 95% CI 1.00, 1.03; P = .008), and the presence of a yellow spot in the fovea (OR 2.24 current vs past or never smoker; 95% CI 1.29, 3.89; P = .004), but not with presence of macular telangiectasia type 2 (OR 2.72; 95% CI 0.45, 16.28; P = .27).
The prevalence of macular telangiectasia type 2 (0.1%) is higher than previously thought. These data are useful in estimating the burden of this condition in the population. The role of smoking in the development of macular telangiectasia type 2 requires further study.
研究 2 型黄斑毛细血管扩张症及相关病变的患病率。
基于人群的队列研究。
地点:1988-1990 年美国比弗大坝城和镇。研究人群:共有 4790 名 43-86 岁人群。观察程序:通过立体眼底照片分级来测量 2 型黄斑毛细血管扩张症。主要观察指标:2 型黄斑毛细血管扩张症的现患率。
人群中基线时 2 型黄斑毛细血管扩张症的现患率为 0.1%(95%可信区间[CI]为 0.09,0.1)。在没有 2 型黄斑毛细血管扩张症的人群中,视网膜透明度丧失、内视网膜层晶体、视网膜血管变钝、黄斑旁局灶性视网膜内色素迁移、黄斑区黄色沉积物和板层孔的频率从视网膜毛细血管扩张血管的 0.06%到板层孔的 1.2%不等。吸烟与色素团块(每包年的优势比[OR]为 1.02;95%CI 为 1.00,1.03;P =.02)、视网膜色素上皮(RPE)脱色素(OR 每包年 1.02;95%CI 为 1.00,1.04;P =.02)、透明度丧失(OR 每包年 1.02;95%CI 为 1.00,1.03;P =.008)和黄斑中心凹黄色斑点的出现(OR 当前吸烟者与既往或从不吸烟者相比为 2.24;95%CI 为 1.29,3.89;P =.004)相关,但与 2 型黄斑毛细血管扩张症的存在无关(OR 2.72;95%CI 为 0.45,16.28;P =.27)。
2 型黄斑毛细血管扩张症(0.1%)的患病率高于之前的估计。这些数据可用于估计人群中这种疾病的负担。吸烟在 2 型黄斑毛细血管扩张症发展中的作用需要进一步研究。